Prevalence of and risk factors for abnormal left ventricular geometrical patterns in hypertensive subjects administered irbesartan

Prevalence of and risk factors for abnormal left ventricular geometrical patterns in hypertensive subjects administered irbesartan

Background: Distinct populations differ in LVH prevalence and impaired LV geometry. Currently, the prevalence of and risk factors for LV geometric patterns in Chinese hypertensives administered irbesartan have not been specifically addressed in large studies. Methods: Totally 10,883 patients (6623 m...

Full description

Bibliographic Details
Main Authors: Cai, A. (Author), Feng, Y.-Q (Author), Huang, C. (Author), Huang, Y. (Author), Zhong, Q. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
abnormal heart left ventricle geometrical pattern
adult
aged
Aged
antihypertensive agent
Antihypertensive Agents
Article
body mass
cardiac patient
cardiovascular risk factor
Chinese
clinical feature
controlled study
Cross-Sectional Studies
cross-sectional study
disease assessment
disease exacerbation
disease risk assessment
dosage schedule comparison
drug dose comparison
drug effect
echocardiography
electrocardiography
Electrocardiography
elevated blood pressure
female
Female
geometry
health survey
heart disease
heart left ventricle
heart left ventricle hypertrophy
heart ventricle
heart ventricle remodeling
Heart Ventricles
human
Humans
hypertension
Hypertension
Hypertrophy, Left Ventricular
irbesartan
Irbesartan
irbesartan-treated hypertension
left ventricular geometry
left ventricular hypertrophy LVH
LVMI
major clinical study
male
Male
middle aged
Middle Aged
monotherapy
neck circumference
odds ratio
pathophysiology
patient coding
prevalence
Prevalence
risk factor
risk factors
Risk Factors
RWT
sex difference
systolic blood pressure
very elderly
waist hip ratio
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items